Long-Yan Yang (Longyan Yang)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Signaling Pathway

Top Venues

Journal of diabetes research

Journal of diabetes investigation

Cell death discovery

International journal of endocrinology

This page only lists publications with an associated author ORCID identifier.

Publications

Simo Liu, Jing Ke, Xiaotong Feng, Zongwei Wang, Xin Wang, Long-Yan Yang, Dong Zhao
The Effect of Canagliflozin on High-Density Lipoprotein Cholesterol and Angiopoietin-Like Protein 3 in Type 2 Diabetes Mellitus. Journal of diabetes research 2024 (2024)
Yan Wang, Kun Li, Shasha Yuan, Caiguo Yu, Ruili Yin, Di Wang, Yongsong Xu, Lijie Zhang, Lingling Wei, Yanan Cheng, Lin Mao, Dong Zhao, Long-Yan Yang
Angiopoietin-like 4 is a potential biomarker for diabetic kidney disease in type 2 diabetes patients. Journal of diabetes investigation (2024)
Simo Liu, Jing Ke, Xiaotong Feng, Zongwei Wang, Xin Wang, Long-Yan Yang, Dong Zhao
The Effect of Canagliflozin on High-Density Lipoprotein Cholesterol and Angiopoietin-Like Protein 3 in Type 2 Diabetes Mellitus. Journal of diabetes research 2024 (2024)
Simo Liu, Jing Ke, Xiaotong Feng, Zongwei Wang, Xin Wang, Long-Yan Yang, Dong Zhao
The Effect of Canagliflozin on High-Density Lipoprotein Cholesterol and Angiopoietin-Like Protein 3 in Type 2 Diabetes Mellitus. Journal of diabetes research 2024 (2024)
Jing Ke, Yan Wang, Simo Liu, Kun Li, YueChao Xu, Long-Yan Yang, Dong Zhao
Relationship of Para and Perirenal Fat and High-Density Lipoprotein and Its Function in Patients with Type 2 Diabetes Mellitus. International journal of endocrinology 2021 (2021)
Xin Wang, Jing Ke, Ying-Jun Zhu, Bin Cao, Rui-Li Yin, Yan Wang, Ling-Ling Wei, Li-Jie Zhang, Long-Yan Yang, Dong Zhao
Dipeptidyl peptidase-4 (DPP4) inhibitor sitagliptin alleviates liver inflammation of diabetic mice by acting as a ROS scavenger and inhibiting the NFκB pathway. Cell death discovery 7 (1) (2021)